Stomach cancer symptoms: Five signs of the deadly condition you need to know

STOMACH cancer affects 6,000 people in the UK each year, but, like all cancers, there is no cure. This means spotting symptoms as early as possible is very important, to ensure treatment is more effective. Here are five signs of the condition you need to know.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

CONCLUSIONS We introduce a 5-gene combination that can predict the survival of GC patients and might be an independent prognostic factor in GC. PMID: 31422414 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Conditions:   Gastric Cancer;   Neoadjuvant Therapy Interventions:   Radiation: SIB-IMRT;   Drug: S-1;   Drug: SOX;   Procedure: Surgery Sponsors:   Jing Jin, M.D.;   Beijing Hope Run Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Authors: Altundag K PMID: 31424695 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
Authors: Zong L, Li H, Li S Abstract PURPOSE: To investigate the effects of neoadjuvant chemotherapy combined with enteral nutrition on perioperative immunity, inflammation and intestinal flora in gastric cancer patients. METHODS: A total of 96 gastric cancer patients scheduled to undergo operation were selected and randomly divided into the observation group (n=48) and the control group (n=48). The patients in the control group were treated with neoadjuvant chemotherapy before operation, while those in the observation group received enteral nutrition before operation based on the treatment in the control group...
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
CONCLUSIONS: In conclusion, it can be safely stated that Trifolirhizin has the potential to be developed as a potent anticancer agent against gastric carcinoma provided further in depth evaluation of this compound is performed. PMID: 31424667 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
CONCLUSIONS: In this meta-analysis, EBV infection rate was significantly higher in males and in diffuse cancer type. However, there was no marked association with lymph node metastasis, age and pathologic tumor stage. Thus, EBV-positive gastric cancer has distinct clinicopathological features. PMID: 31424666 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
Authors: Li T, Xiang PLB Abstract PURPOSE: To study the clinical effect of endoscopic mucosal resection (EMR) in the treatment of early gastric cancer (EGC), and to evaluate the recovery and prognosis, so as to provide references for clinical selection of treatment methods. METHODS: 120 patients with EGC were selected and randomly divided into the EMR group and the radical surgery group. Before surgery and 3 days after surgery, the levels of traumatic response-related indexes in serum [adrenocorticotropic hormone (ACTH), cortisol (Cor), gastrin (GAS) and motilin (MTL)] were assessed. Before surgery, 3 months an...
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
CONCLUSIONS: The superiority of laparoscopic gastrectomy towards the open technique is widely accepted, yet the proven acceptance of minimally invasive robotic techniques is still debated and not scientifically established. Technical challenges are the main point of discussion among the experts on the field, as well as the advantages of laparoscopic and robotic assisted gastrectomy over the conventional open. This review provides a comparison on technical aspects, the short and long term outcomes of open and minimally invasive gastrectomy with D2 lymphadenectomy in early and advanced gastric cancer. PMID: 31424638 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
CONCLUSION: Although a technically demanding and time-consuming procedure, LGD2 offers the advantages of minimal invasion and can achieve the same degree of radical resections, harvested lymph nodes and short- or long-term prognosis for the treatment of locally AGC. PMID: 31424636 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
Sialyl Lewis A (sLeA, also known as CA19-9), a tetrasaccharide selectively and highly expressed on advanced adenocarcinomas including colon, stomach, and pancreatic cancers, has long been considered as an attractive target for active and passive vaccination. While progress in antibodies targeting tumor-associated protein antigens resulted in an impressive array of therapeutics for cancer treatment, similar progress in exploiting tumor-associated carbohydrate antigens, such as sLeA, has been hampered by the lack of a detailed understanding of the singular characteristics of these antigens. We have addressed this issue by an...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Health